Pharmala Biotech Holdings Inc. (CSE: MDMA)
Canada
· Delayed Price · Currency is CAD 0.0850
0.00 (0.00%)
Sep 25, 2024, 11:38 AM EDT
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 6.95 million as of September 26, 2024. Its market cap has decreased by -59.62% in one year.
Market Cap
6.95M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 6.95M, an increase of 4.71%. That is a compound annual growth rate of 1.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2024 | 6.95M | -42.86% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries Inc. | 3.35B |
| Trulieve Cannabis Corp. | 3.01B |
| Cresco Labs Inc. | 803.26M |
| Ayr Wellness Inc. | 273.68M |
| Planet 13 Holdings Inc. | 263.38M |
| Jushi Holdings Inc. | 145.61M |
| Grown Rogue International Inc. | 139.19M |
| MariMed Inc. | 88.49M |